Paradigm Therapeutics raises $12.5 million from Eshelman Ventures to support the development of SD-101, a topical therapy for Epidermolysis Bullosa, and plans for NDA submission in 2025.
Amount Raised
$12.5 Million
Round Type
Funding Round
Mount PleasantBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Paradigm Therapeutics, Inc. has announced a $12.5 million investment by Eshelman Ventures, LLC. This funding will support the completion of development activities for SD-101 (Zorblisa™) and an NDA submission in late 2025. Dr
Quick answer
Paradigm Therapeutics raised $12.5 Million in a Funding Round round, dated May 6, 2025. Investors: Eshelman Ventures, LLC. Paradigm Therapeutics is based in Mount Pleasant, South Carolina, United States.
- How much did Paradigm Therapeutics raise?
- Paradigm Therapeutics raised $12.5 Million in a Funding Round round on May 6, 2025.
- Who invested in Paradigm Therapeutics?
- Eshelman Ventures, LLC is named as investors in this round.
- What does Paradigm Therapeutics do?
- Paradigm Therapeutics, Inc. is a privately held, clinical-stage pharmaceutical company focused on developing innovative therapies to address critical medical needs in the treatment of rare diseases.
- Where is Paradigm Therapeutics based and how big is it?
- Paradigm Therapeutics is based in Mount Pleasant, South Carolina, United States. Fundz records about 4 employees.
- Who are the decision-makers at Paradigm Therapeutics?
- Fundz holds 1 contact at Paradigm Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Paradigm Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Ensho Therapeutics raised $23M on June 12, 2025.
- Mezzion Pharma raised $20M (Funding Round) on June 11, 2025.
- Azora Therapeutics, Inc. (DE) raised $4.8M on May 2, 2025.
- Oratech Pharmaceuticals raised $37M (Corporate Round) on April 28, 2025.
- Retension Pharmaceuticals raised $12M on April 22, 2025.
- Pathos AI raised $283M on April 17, 2025.
Who to call at Paradigm Therapeutics, and when
A new round usually means Paradigm Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Paradigm Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Paradigm Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Paradigm Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Paradigm Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Paradigm Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.